Corvus Pharmaceuticals (CRVS) Shares Outstanding (Entity) (2015 - 2026)

Corvus Pharmaceuticals (CRVS) Shares Outstanding (Entity) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Corvus Pharmaceuticals 1.25 Bn 1.04 Bn - 84.12 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 84.12 Mn
Mar 31, 2026 84.09 Mn
Dec 31, 2025 74.70 Mn
Sep 30, 2025 74.68 Mn
Jun 30, 2025 74.51 Mn
Mar 31, 2025 68.17 Mn
Dec 31, 2024 67.90 Mn
Sep 30, 2024 62.58 Mn
Jun 30, 2024 62.55 Mn
Mar 31, 2024 49.04 Mn
Dec 31, 2023 49.04 Mn
Sep 30, 2023 49.04 Mn
Jun 30, 2023 48.90 Mn
Mar 31, 2023 46.57 Mn
Dec 31, 2022 46.55 Mn
Sep 30, 2022 46.55 Mn
Jun 30, 2022 46.55 Mn
Mar 31, 2022 46.55 Mn
Dec 31, 2021 46.55 Mn
Sep 30, 2021 46.55 Mn